Zealand Pharma ^Public

Zealand Pharma is a biotechnology company that specializes in developing peptide-based medicines. They have a diverse pipeline of drug candidates and a portfolio of products under license collaborations with major pharmaceutical companies. Their first invented medicine, lixisenatide, is marketed globally for the treatment of Type 2 diabetes. They also have other drugs in various stages of development for conditions such as ischemic reperfusion injuries and short bowel syndrome. Zealand Pharma is based in Copenhagen, Denmark and is known for their scientific expertise in peptide therapeutics.